Safety and Tolerability of Omalizumab in Adults and Adolescents With Severe Allergic Asthma

NCT00482248 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

132

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Omalizumab

Sponsor

Novartis

Collaborators

[object Object]